Giorgio Cavallini

Giorgio Cavallini

Auto-generated profile, based on publicly available information

Giorgio Cavallini

Andrological Section, Gynepro Medical Team, Bologna, Italy

Research Focus & Metrics

Academic Career Length

29Years (1998-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2006 in Asian Journal of Andrology
Verified
Journal Article
Open access
GCGiorgio Cavallini
Giorgio Cavallini
AJA publishes new findings in basic and clinical (including modern, traditional and epidemiological) research on Andrology.

10 September 2004 in Journal of Andrology
Verified
Journal Article
Closed access
PDF file
GCGiorgio Cavallini
Giorgio Cavallini
AFAnna Pia Ferraretti
Anna Pia Ferraretti
LGLuca Gianaroli
Luca Gianaroli
GBGiulio Biagiotti
Giulio Biagiotti
GVGiovanni Vitali
Giovanni Vitali

1 July 2001 in BJU International
Verified
Journal Article
Open access
PDF file
GBG. Biagiotti
G. Biagiotti
GCG. Cavallini
G. Cavallini
Objective To detect whether oral acetyl‐ l ‐carnitine might be useful in the acute and early chronic phases of Peyronie's disease, compared with tamoxifen, a drug currently in use. Patients and methods The study included 48 patients with Peyronie's disease (15 acute and 33 initial chronic), randomized equally into two groups. The first group used tamoxifen 20 mg twice daily for 3 months and the second acetyl‐ l ‐carnitine 1 g twice daily for 3 months. The disease and stages were diagnosed and identified using a history, objective examination, pharmacologically induced erection, autophotography during erection, and basic and dynamic colour Doppler ultrasonography. Penile curvature, plaque size, pain and disease progression were assessed. The differences between the groups or between the variables before and after therapy were compared using analysis of variance or the chi‐squared test. Results Acetyl‐ l ‐carnitine was significantly more effective than tamoxifen in reducing pain and in inhibiting disease progression. Acetyl‐ l ‐carnitine reduced penile curvature significantly, while tamoxifen did not; both drugs significantly reduced plaque size. Tamoxifen induced significantly more side‐effects than acetyl‐ l ‐carnitine. Conclusions These results suggest that acetyl‐ l ‐carnitine is significantly more effective and safe than tamoxifen in the therapy of acute and early chronic Peyronie's disease.


11 December 2002 in BJU International
Verified
Journal Article
Open access
PDF file
GBG. Biagiotti
G. Biagiotti
GCG. Cavallini
G. Cavallini
FMF. Modenini
F. Modenini
GVG. Vitali
G. Vitali
LGL. Gianaroli
L. Gianaroli
Objective To assess whether the peak systolic velocity (PSV), end‐diastolic velocity (EDV) and resistive index (RI) of testicular arteries may be useful in distinguishing the various causes of dyspermia when compared with follicle‐stimulating hormone (FSH) and testicular volume. Patients, subjects and methods The study included nine men with obstructive and 20 with unobstruc‐tive azoospermia, 17 with oligoasthenospermia and clinical varicoceles, with male accessory glans inflammation (MAGI), 38 with undetermined oligoasthenospermia, 19 with MAGI, 11 with clinical varicoceles, 32 subjects with normal sperm analysis and recent paternity (fertile controls), and 15 with normal sperm analysis and a varicocele with recent paternity (fertile + varicoceles). Testicular volume, FSH, PSV, EDV and RI were compared among the dyspermic and/or control groups using analysis of variance. Results The PSV and RI were useful for identifying the different groups of patients, while EDV, FSH and testicular volume were not. Men with varicoceles, varicoceles + MAGI or fertile with varicoceles had the highest PSV and RI; fertile controls, those with obstructive azoospermia and MAGI had similar PSVs and RIs, those with unexplained oligoasthenospermia had a significantly lower PSV and RI, and men with unobstructive azoospermia had the lowest PSV and RI. Conclusions The RI and PSV are reliable indicators for routine clinical use to identify infertile/dyspermic men, while EDV, FSH and testicular volume are not. The RI and especially PSV clearly differentiated obstructive from unobstructive azoospermia.

12 May 2002 in BJU International
Verified
Journal Article
Closed access
PDF file
GCG. Cavallini
G. Cavallini
GBG. Biagiotti
G. Biagiotti
AKA. Koverech
A. Koverech
GVG. Vitali
G. Vitali